IL33 and Granuloma: ST2 deficiency or blockade of IL-33 using soluble ST2 treatment or neutralizing antibodies resulted in obvious less Th2 cytokine production and Th2-mediated pathology in livers, including marked decreases in granuloma size and fibrosis extent (McHedlidze et al., 2013).